The FDA's statement, released in a climate of heavy pressure from the chemical industry, is in contrast to developments in Canada. On April 19 the Canadian government began a 60-day public comment period on whether polycarbonate baby bottles should be banned in the country. Observers have said a comprehensive ban on polycarbonate is even possible up north in the near future.
For its part, Thermo Fisher Scientific Inc., makers of Nalgene bottles, have announced that they will stop using polycarbonate. Wal-Mart says it expects all baby bottles it carries to be free of the material by early next year, and Toys R Us has discussed a similar plan.
If such major players are clearly expressing concern over BPA, what legs does the FDA have to stand on for its reassurance? According to Reuters, the FDA's associate commissioner for science, Norris Alderson, said the feds are reviewing safety concerns, and pointed to two industry-funded studies claiming it poses no risk.